Literature DB >> 3260818

Haemophilus influenzae meningitis in the presence of cerebrospinal fluid shunts.

S Stern1, R Bayston, R J Hayward.   

Abstract

Haemophilus influenzae is an uncommon pathogen in shunted patients and there is uncertainty about optimal management. We report here two cases which were managed differently, with different outcomes. The first case was treated with chloramphenicol and the shunt was not removed. Although there were subsequent episodes of respiratory infection, the outcome was satisfactory. The second case was treated with cefuroxime and the shunt was exteriorized. Re-shunting was followed by relapse and further shunt removal. This and other case reports suggest that in Haemophilus meningitis in shunted patients treatment need not involve shunt removal, but that this is so only if appropriate antimicrobials such as chloramphenicol are used.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3260818     DOI: 10.1007/bf00270910

Source DB:  PubMed          Journal:  Childs Nerv Syst        ISSN: 0256-7040            Impact factor:   1.475


  10 in total

1.  Haemophilus influenzae meningitis in the presence of a cerebrospinal fluid shunt.

Authors:  R M Petrak; J C Pottage; A A Harris; S Levin
Journal:  Neurosurgery       Date:  1986-01       Impact factor: 4.654

2.  Cefuroxime versus ampicillin and chloramphenicol for the treatment of bacterial meningitis. Report from a Swedish Study Group.

Authors: 
Journal:  Lancet       Date:  1982-02-06       Impact factor: 79.321

3.  Treatment of Haemophilus influenzae type b meningitis in children with cerebrospinal fluid shunts.

Authors:  M B Rennels; E R Wald
Journal:  J Pediatr       Date:  1980-09       Impact factor: 4.406

4.  Prospective randomized study of therapy in cerebrospinal fluid shunt infection.

Authors:  H E James; J W Walsh; H D Wilson; J D Connor; J R Bean; P A Tibbs
Journal:  Neurosurgery       Date:  1980-11       Impact factor: 4.654

5.  Cerebrospinal fluid antibiotic levels during treatment of shunt infections.

Authors:  S L Wald; R L McLaurin
Journal:  J Neurosurg       Date:  1980-01       Impact factor: 5.115

6.  The penetration of cefuroxime into the cerebrospinal fluid through inflamed and non-inflamed meninges.

Authors:  C Müller; A Netland; A F Dawson; E Andrew
Journal:  J Antimicrob Chemother       Date:  1980-03       Impact factor: 5.790

7.  Infections of cerebrospinal fluid shunts: epidemiology, clinical manifestations, and therapy.

Authors:  S C Schoenbaum; P Gardner; J Shillito
Journal:  J Infect Dis       Date:  1975-05       Impact factor: 5.226

8.  Ventriculoperitoneal shunt-associated infection due to Haemophilus influenzae.

Authors:  P A Patriarca; B A Lauer
Journal:  Pediatrics       Date:  1980-05       Impact factor: 7.124

9.  Haemophilus influenzae infections of cerebrospinal fluid shunts. Report of two cases.

Authors:  S J Lerman
Journal:  J Neurosurg       Date:  1981-02       Impact factor: 5.115

10.  Gram-negative cerebrospinal fluid shunt-associated infections.

Authors:  C J Sells; D B Shurtleff; J D Loeser
Journal:  Pediatrics       Date:  1977-04       Impact factor: 7.124

  10 in total
  3 in total

1.  Cerebrospinal fluid shunt infections by unencapsulated Haemophilus influenzae.

Authors:  L C Hellbusch; R G Penn
Journal:  Childs Nerv Syst       Date:  1989-10       Impact factor: 1.475

2.  Invasive disease due to nontypeable Haemophilus influenzae among children in Arkansas.

Authors:  Joshua M O'Neill; Joseph W St Geme; David Cutter; Elisabeth E Adderson; Juliana Anyanwu; Richard F Jacobs; Gordon E Schutze
Journal:  J Clin Microbiol       Date:  2003-07       Impact factor: 5.948

3.  Cerebral fluid edema: an unusual complication of ventriculoperitoneal shunts.

Authors:  F J Villarejo; A Pascual; F Carceller; J A Bencosme; C Pérez Díaz; F Goyenechea
Journal:  Childs Nerv Syst       Date:  2004-01-29       Impact factor: 1.475

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.